20405 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines Morphinan derivatives, e.g. morphine, codeine
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
#3902Opioid agonist/antagonist combinations
#3903Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#3904Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#3905Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#3906Pharmaceutical compositions
#3907Compositions for affecting weight loss
#3908Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
#3909Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunction
#3910Pharmaceutical compositions
#3911GABA RECEPTOR MEDIATED MODULATION OF NEUROGENESIS
#3912Modified-release pharmaceutical compositions
#3913Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone
#3914Methods and compositions for the treatment of brain reward system disorders by combination therapy
#3915Synthesis of R-N-methylnaltrexone
#3916Pharmaceutical formulation
#3917Oxymorphone controlled release formulations
#3918OXYMORPHONE CONTROLLED RELEASE FORMULATIONS
#3919OXYMORPHONE CONTROLLED RELEASE FORMULATIONS
#3920Multi-layered coating technology for taste masking
#3921Local anesthetic compositions
#3922Methods for treatment of parkinson's disease
#3923METHODS AND COMPOSITIONS FOR TREATING PAIN
#3924Methods of inhibiting TNFα activity in the blood of a patient
#3925Active substance combination
#3926Transdermal formulation comprising an opioid analgesic and an aloe composition
#3927EFFERVESCENT FORMULATIONS COMPRISING APOMORPHINE
#3928Modafinil-based neurorehabilitation of impaired neurological function associated with brian injury
#3929RYANODINE RECEPTOR BLOCKERS FOR TREATING PAIN
#3930Compounds and compositions for prevention of overdose of oxycodone
#3931Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
#3932Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
#3933Pharmaceutical compositions for prevention of overdose or abuse
#3934Inhibitors of ABC drug transporters at the blood-brain barrier
#3935Sustained release formulations of nalbuphine
#3936Dried milled granulate and methods
#3937ABUSE-PROOFED DOSAGE FORM
#3938Use of non-opiates for the potentation of opiates
#3939Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid
#3940Pharmaceutical composition for the treatment of acute disorders
#3941Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
#3942COMPOSITIONS AND METHODS FOR CONTROLLING ABUSE OF MEDICATIONS
#3943Pharmaceutical formulation containing irritant
#3944Delivery of muscle relaxants through an inhalation route
#3945Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#3946Compositions and methods for treating gastrointestinal hypomotility and associated disorders
#3947Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
#3948Methods of treating inflammation associated with viral infection with anti-TNF antibodies
#3949Diphenhydramine containing dosage form
#3950Morphine sulfate microgranules, method for preparing same and compositions containing same
#3951Morphine controlled release system
#3952Process for the production of an abuse-proofed dosage form
#3953Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions
#3954Delivery of antihistamines through an inhalation route
#3955Delivery of sedative-hypnotics through an inhalation route
#3956Two-component pharmaceutical composition for the treatment of pain
#3957Alkaloid formulations
#3958Methods of inhibiting TNF-α in patients with Crohn's disease
#3959Delivery of antipsychotics through an inhalation route
#3960Glutamate agents in the treatment of mental disorders
#3961Methods and systems for enabling and stabilizing tooth movement
#3962Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
#3963Controlled release tramadol formulations
#3964Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
#3965Opioid Sustained Release Formulation
#3966Formulation and Method for Preventing Infection
#3967Use of opioid antagonists to attenuate endothelial cell proliferation and migration
#3968Carrier
#3969Delivery of drug esters through an inhalation route
#3970Nicotinic-opioid synergy for analgesia
#3971Controlled release formulations of opioid and nonopioid analgesics
#3972Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
#3973Delivery of erectile dysfunction drugs through an inhalation route
#3974Delivery of analgesics through an inhalation route
#3975Delivery of physiologically active compounds through an inhalation route
#3976Delivery of diphenhydramine through an inhalation route
#3977Combined immediate release and extended release analgesic composition
#3978Multiparticulate modified release composition
#3979Treatment of dependence withdrawal
#3980Methods and compositions for treating migraine pain
#3981Recombinant anti-TNF-α antibodies
#3982Delivery of anti-migraine compounds through an inhalation route
#3983Novel therapeutic uses for nalmefene
#3984Delivery of antidepressants through an inhalation route
#3985Transdermal pain control method and device
#3986Method of providing sustained analgesia with buprenorphine
#3987Delivery of compounds for the treatment of Parkinson's through an inhalation route
#3988Delivery of beta-blockers through an inhalation route
#3989Reduction of postoperative pain medication
#3990Method for treating erectile dysfunction and increasing libido in men
#3991Sublingual coated tablet of fentanyl
#3992Therapeutic wound care product
#3993Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
#3994Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid
#3995Pharmaceutical combination for the treatment of spasticity and/or pain
#3996Tamper resistant transdermal dosage form
#3997Pharmaceutical combinations of hydrocodone and naltrexone
#3998Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
#3999Crush resistant delayed-release dosage forms
#4000Abuse-proofed dosage form
#4001In situ controlled release drug delivery system
#4002SYSTEM AND METHOD FOR SUPPRESSING A COUGH
#4003Process for the production of an abuse-proofed dosage form
#4004Sequestered antagonist formulations
#4005Chemically modified small molecules
#4006Delivery of antiemetics through an inhalation route
#4007Opiopathies
#4008Methods and compositions for deterring abuse of orally administered pharmaceutical products
#4009Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone
#4010Functionalized drugs and polymers derived therefrom
#4011Controlled release oxycodone compositions
#4012Controlled release oxycodone compositions
#4013Multiparticulates
#4014Method for deterring abuse of opioids by combination with non-release formulation of emetic
#4015Method for treating eating disorders by selective extinction with transdermal naloxone
#4016Sustained-release preparations and method for producing the same
#4017Delivery of stimulants through an inhalation route
#4018Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
#4019Pharmaceutical compositions for nasal delivery
#4020System and method for intranasal administration of lorazepam
#4021Polymorphic forms of naltrexone
#4022Compositions for affecting weight loss
#4023Effervescent formulations comprising apomorphine
#4024Recombinant A2-specific TNFα-specific antibodies
#4025Dosage form containing diphenhydramine and another drug
#4026High yielding multiple disease resistant/tolerant stable variety ‘Madakini’ of opium poppy
#4027Ceramic structures for prevention of drug diversion
#4028Methods of treating rheumatoid arthritis with anti-TNF antibodies
#4029Salmeterol superfine formulation
#4030Method of increasing gastric emptying
#4031Compositions and methods for treating or preventing pain
#4032Methods and compositions for therapeutic treatment
#4033Methods and compositions for treating pain
#4034Composition for nasal absorption
#4035Abuse-resistant pharmaceutical compositions
#4036Compositions for affecting weight loss
#4037Controlled release oxycodone compositions
#4038Remedies for neuropathic pain and model animals of neuropathic pain
#4039Nutritional supplement compositions
#4040Topical oral dosage forms containing bismuth compounds
#4041Intranasal opioid compositions, delivery devices and methods of using same
#4042Adhesive composition for dermal patch and production process thereof
#4043Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
#4044Abuse-resistant opioid solid dosage form
#4045Analgesic compositions containing buprenorphine
#4046Use of tellurium containing compounds as nerve protecting agents
#4047Analgesic compositions containing buprenorphine
#4048Analgesic compositions containing buprenorphine
#4049Abuse resistant opioid dosage form
#4050Controlled release oxycodone compositions
#4051Phenylepherine containing dosage form
#4052Therapeutic or preventive agent for nausea/vomiting
#4053Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
#4054Sigma ligands for neuronal regeneration and functional recovery
#4055Methods and compositions for treating nociceptive pain
#4056Tamper-resistant oral opioid agonist formulations
#4057Pharmaceutical compositions and methods for the prevention of drug misuse
#4058Method for decreasing opioid metabolism
#4059Therapeutic agents for drug/substance dependence
#4060Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
#4061Methods of inhibiting or neutralizing TNFα in patients with tissue injury
#4062Noscapine derivatives as adjuvant compositions and methods of use thereof
#4063Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
#4064Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof
#4065Method of treating psoriasis using human anti-TNF antibodies and fragments
#4066Methods for the treatment of back pain
#4067Controlled phase composition technology as an improved process for protection of drugs
#4068Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
#4069Sigma-2 receptor agonists and their use in the treatment of HIV infection
#4070System for identification of a pharmaceutical product
#4071Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same
#4072Abuse-proofed oral dosage form
#4073Compositions and method for enhancing the therapeutic activity of opiods in treatment of pain
#4074Promethazine containing dosage form
#4075Abuse-deterrent drug formulations
#4076Sustained release formulations of guaifenesin and additional drug ingredients
#4077Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
#4078Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
#4079Process for making aqueous coated beadlets
#4080Pharmaceutical compositions
#4081Transdermal delivery of cannabidiol
#4082Dosage form containing multiple drugs
#4083Opioid and opioid-like compounds and uses thereof
#4084Neuroprotective properties of dextrorotatory morphinans
#4085Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
#4086Method of treating the syndrome of coronary heart disease risk factors in humans
#4087Naltrexone long acting formulations and methods of use
#4088Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
#4089Pharmaceutical preparation containing oxycodone and naloxone
#4090Methods for treating alcoholism
#4091Matrix for sustained, invariant and independent release of active compounds
#4092Methods for treating alcoholism
#4093Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
#4094Lozenge for delivery of dextromethorphan
#4095Process for the production of an abuse-proofed solid dosage form
#4096Dosage form containing promethazine and another drug
#4097Dosage form containing a morphine derivative and another drug
#4098Dosage form containing promethazine and another drug
#4099Pharmaceutical compositions and methods for peptide treatment
#4100Pain relief composition, method to form same, and method to use same
#4101Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#4102Active substance combination
#4103Abuse-safeguarded dosage form
#4104Prolonged release bioadhesive therapeutic systems
#4105Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
#4106Unit dose of material in system and method
#4107Single tank process for preparing tannate liquid and semi-solid dosage forms
#4108Method of preventing abuse of opioid dosage forms
#4109Method for reducing pain
#4110Opioid-receptor antagonists in transdermal systems having buprenorphine
#4111Abuse-resistant pharmaceutical dosage form
#4112Synergistic l-methadone compositions and methods of use thereof
#4113Methods and systems for enabling and stabilizing tooth movement
#4114Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
#4115Tamper-resistant oral opioid agonist formulations
#4116Use of compounds that are effective as selective opiate receptor modulators
#4117Abuse-resistant hydrocodone compounds
#4118Controlled release formulations
#4119Controlled release dosage forms using acrylic polymer, and process for making
#4120Abuse-resistant sustained-release opioid formulation
#4121Treatment of cocaine abuse using N-substituted derivatives of morphinan
#4122Management of postoperative pain
#4123Controlled release formulations of opioid and nonopioid analgesics
#4124Pressurised metered dose inhalers containing solutions of beta-2 agonists
#4125Formoterol superfine formulation
#4126Abuse-proofed dosage system
#4127(2S)-amino(phenyl)acetic acid and derivatives as alpha2delta voltage-gated calcium channel ligands
#4128(2S)-amino(phenyl)acetic acid and derivatives as αδ voltage-gated calcium channel ligands
#4129Aporphine esters and their use in therapy
#4130Pharmaceutical composition and method for treating hypogonadism
#4131Analgesics for nasal administration
#4132Combination of selected opioids with other active compounds for treatment of urinary incontinence
#4133Prodrug composition
#4134Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
#4135Biodegradable, antibiotic, controlled release tape
#4136Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
#4137Treatment of effect of chemicals with their ultradilute stereoisomers
#4138Analgesics
#4139Rapidly disintegrating films for delivery of pharmaceutical of cosmetic agents
#4140Pharmaceutical composition and method for treating hypogonadism
#4141Drug coating providing high drug loading
#4142Pharmaceutical composition and method for treating hypogonadism
#4143Methods and compositions for deterring abuse of opioid containing dosage forms
#4144Opioid and opioid-like compounds and uses thereof
#4145Once-a-day, oral, controlled-release, oxycodone dosage forms
#4146Ibuprofen and narcotic analgesic compositions
#4147Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
#4148Method for rapid detoxification of addiction
#4149Tamper-resistant oral opioid agonist formulations
#41501-alkyl-4-(3-substitutedphenyl)piperidines
#4151Pharmaceutical combinations of cox-2 inhibitors and opiates
#4152Oros push-stick for controlled delivery of active agents
#4153Delivery of sedative-hypnotics through an inhalation route
#4154Buprenorphine formulations for intranasal delivery
#4155Opioid delivery system
#4156Anti-viral compounds
#4157Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
#4158Aerosol formulations and aerosol delivery of scopolamine
#4159Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions
#4160Delivery of opioids through an inhalation route
#4161Extended release formulations of opioids and method of use thereof
#4162Methods of treating carcinoma using anti-TNF antibodies and peptides
#4163Oral transmucosal methadone
#4164Penis enlargement
#4165Oral dosage form comprising a therapeutic agent and an adverse-effect agent
#4166Method of treating acute pain with a unitary dosage form comprising ibuprofen and oxycodone
#4167Method for treating erectile dysfunction and increasing libido in men
#4168Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
#4169Compositions and methods for treating pain
#4170Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
#4171Method for treating erectile dysfunction and increasing libido in men
#4172In situ gelling drug delivery system
#4173Use of methylnaltrexone and related compounds
#4174Buprenorphine microspheres
#4175Use of active ingredients having a mu-opioid receptor agonist action and an opiod receptor antognist action, as combination drugs for the treatment of cancer
#4176Compositions for delivering therapeutic agents across the oral mucosa
#4177Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone
#4178Methods and materials for the treatment of pain comprising opioid antagonists
#41796-aminomorphinane derivatives, method for production and use thereof
#4180Methods of inhibiting TNFα in patients with cancer
#4181Novel therapeutic use of a thienylcyclohexylamine derivative
#4182Methods for administering active agents to CYP 2D6 sensitive patients
#4183Implantable polymeric device for sustained release of nalmefene
#4184Implantable polymeric device for sustained release of dopamine agonist
#4185Abuse-proofed dosage form
#4186Analgesic and anti-inflammatory compositions comprising domperidone and methods of using the same
#4187Compositions of Alpha3beta4 Receptor antagonists and opioid agonist analgesics
#4188Bioerodible sustained release drug delivery systems
#4189Sustained release opioid formulations and method of use
#4190Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
#4191Use of methylnaltrexone in treating gastrointestinal dysfunction in equines
#4192Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors
#4193Treatment of central neuropathic pain
#4194Treatment of dyskinesia
#4195Use of methylnaltrexone to treat irritable bowel syndrome
#4196Selective analgesic agents
#4197Tamper resistant transdermal dosage form
#4198Methods and compositions for controlled release of drugs
#4199Pharmaceutical formulations comprising naltrexone and/or bupropion
#4200Compounds and combinations thereof for treating neurological and psychiatric conditions